Stem Cell and Regenerative Medicine Expected to Become a $24 Billion Market by 2017
Los Angeles, CA (PRWEB) May 12, 2016 -- Biotech companies and professional sports associations are making big investments in the field of regenerative medicine, particularly in the area of sports medicine and orthopedics. Current estimates suggest that regenerative medicine research will grow into a $24.7 billion market in 2017.
With its minimally invasive nature and advanced healing capabilities, more and more medical practitioners across the board are turning to stem cells, platelet rich plasma, and prolotherapy (collectively known as regenerative medicine) to treat chronic pain and injuries that have not responded to, or have seen limited results with more traditional treatments and surgery.
For more information about prolotherapy, visit: http://MOSM.com/Prolotherapy-Service/
Professional athletes in particular have been relying on regenerative treatments to help manage longstanding and potentially career ending injuries. In fact, the National Football League Players Association made a multi-million dollar, 10 year research grant to Harvard Medical School to help further develop the promising therapies.
Board-certified orthopedic surgeon Steven Meier, M.D. is a global regenerative medicine expert. “As more and more people learn of the benefits and medical applications for prolotherapy and stem cells, especially in treating common orthopedic conditions like chronic joint, knee, and lower back pain, it’s only natural that larger investments and more research will follow,” said Dr. Meier.
Meet orthopedic surgeon Dr. Steven Meier, M.D. http://MOSM.com/Orthopedic-Surgeon-Los-Angeles/
Stem cells have the ability to differentiate into a variety of different cell types, which can help to repair and speed up the healing of damaged tissue. Platelet rich plasma (PRP) treatments use a sample of the patient’s own whole blood, which contains growth factors and activates cell signals, to create a more concentrated form used to treat injuries, and even complement surgery in some cases.
“We are working in a revolutionary moment in medicine,” said Dr. Meier. “Regenerative medicine will impact how we treat numerous injuries and diseases in the future.”
In 15 years of medical practice, Dr. Meier proves his commitment to caring for patients with the most leading-edge medicine. His ongoing work to heal through multiple therapeutic techniques exemplifies how Dr. Meier’s medical mission is #KeepingYouActive.
Steven Meier, M.D. is a board-certified orthopedic surgeon and sports medicine doctor in Beverly Hills, California. As a renowned expert in the most advanced techniques for shoulder and knee surgery, Dr. Meier is highly sought-after for his cutting-edge joint preservation and restoration procedures. He graduated with honors from Loyola Medical School in Chicago, received his residency training at Northwestern University, and completed his fellowship in sports medicine and arthroscopic surgery at the University of California San Diego. To learn more about Dr. Meier and his practice, please visit http://www.MOSM.com/ or call 310.736.2793.
Meier Orthopedic Sports Medicine
8641 Wilshire Blvd #215
Beverly Hills, CA 90211
(310) 853-1029
meierinquiry(at)gmail(dot)com
Risa Goldman, Goldman Marketing Group, +1 818-861-7092, [email protected]
Share this article